Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-04

FDA Approved: LOPINAVIR AND RITONAVIR — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' original application for a generic lopinavir/ritonavir product for the treatment of HIV-1 infection in combination with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

ORIG AP for LOPINAVIR AND RITONAVIR (LOPINAVIR AND RITONAVIR)